We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Several Cranberry Extracts Act to Prevent Infection by Reducing Bacterial Adhesion

By LabMedica International staff writers
Posted on 02 Aug 2016
Print article
Image: Some compounds in cranberries act to prevent urinary tract infections by keeping infectious bacteria from adhering to the lining of the urinary tract (Photo courtesy of the Worcester Polytechnic Institute).
Image: Some compounds in cranberries act to prevent urinary tract infections by keeping infectious bacteria from adhering to the lining of the urinary tract (Photo courtesy of the Worcester Polytechnic Institute).
Various chemical compounds have been isolated from cranberries and analyzed to determine their ability to prevent infection by reducing or eliminating adhesion of bacteria to biological surfaces.

Cranberry juice has been long used to in natural medicine to prevent infections because of its ability to prevent or reduce the adhesion of bacteria to the host surface. Proanthocyanidins (PACs) comprise of one of the major classes of phytochemicals found in cranberry, which have been extensively studied and found effective in combating adhesion of pathogenic bacteria. The ability of other cranberry constituents to prevent bacterial adhesion remains to be determined.

Investigators at Worcester Polytechnic Institute (MA, USA) and the University of Massachusetts, Dartmouth (USA) used advanced atomic force microscopy techniques to evaluate the effect of various cranberry extracts on bacterial adhesion.

For this purpose the investigators used two strains of Escherichia coli: the pathogenic clinical bacterial strain E. coli B78 and the non-pathogenic control E. coli HB101. The preparations tested included crude cranberry juice extract (CCE); three fractions containing flavonoid classes including proanthocyanidins, anthocyanins and flavonols; selected sub-fractions, and the commercially available flavonol glycoside, quercetin-3-O-galactoside.

Results published in the May 13, 2016, online edition of the journal Food & Function revealed that adhesion forces of the non-pathogenic HB101 lab strain were small and did not change with cranberry treatments, whereas the adhesion forces of the pathogenic E. coli strain B78 showed a significant decrease when treated with cranberry juice extract or fractions. In particular, the fractions that contained flavonols in addition to PACs were more efficient at lowering the force of adhesion.

The sub-fractions containing flavonol glycosides (from juice, fruit, and commercial quercetin) all resulted in reduced adhesion of the pathogenic bacteria to the model probe. This strongly suggested that there was an anti-adhesive role for other classes of cranberry compounds in conjunction with already known PACs, and this finding may have implications for development of alternative anti-bacterial treatments.

"With the emergence of new superbugs that are resistant to current antibiotics, our hope is to better understand the mechanisms of bacterial infection so we can identify potential new antibiotic drug targets," said senior author Dr. Terri Camesano, professor of chemical engineering at Worcester Polytechnic Institute. ""This is an excellent collaboration that pairs what we do on the biophysical side at Worcester Polytechnic Institute with the work that University of Massachusetts, Dartmouth does on the biochemical side."

Related Links:
Worcester Polytechnic Institute
University of Massachusetts, Dartmouth
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more